Bravo-Jimenez M, Sharma S, Karimi-Abdolrezaee S
Mol Neurodegener. 2025; 20(1):20.
PMID: 39972469
PMC: 11837473.
DOI: 10.1186/s13024-025-00811-6.
Li L, Peng R, Wang C, Chen X, Gheyret D, Guan S
Cell Commun Signal. 2025; 23(1):70.
PMID: 39923080
PMC: 11806581.
DOI: 10.1186/s12964-025-02071-9.
Solar P, Brazda V, Bares M, Zamani A, EmamiAref P, Joukal A
Front Cell Neurosci. 2025; 18():1525415.
PMID: 39839349
PMC: 11747387.
DOI: 10.3389/fncel.2024.1525415.
Mwale P, Hsieh C, Yen T, Jan J, Taliyan R, Yang C
Mol Neurodegener. 2025; 20(1):7.
PMID: 39827337
PMC: 11742494.
DOI: 10.1186/s13024-025-00801-8.
Mikolaskova I, Zvarik M, Szaboova K, Tibenska E, Durmanova V, Suchankova M
Int J Mol Sci. 2024; 25(23).
PMID: 39684475
PMC: 11641687.
DOI: 10.3390/ijms252312765.
Inflammation and DNA methylation in Alzheimer's disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain.
Seddon A, MacArthur C, Hampton M, Stevens A
Redox Rep. 2024; 29(1):2428152.
PMID: 39579010
PMC: 11587723.
DOI: 10.1080/13510002.2024.2428152.
Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity.
Elyan N, Schwenkenbecher P, Grote-Levi L, Becker J, Merten R, Christiansen H
Discov Oncol. 2024; 15(1):656.
PMID: 39546075
PMC: 11568079.
DOI: 10.1007/s12672-024-01560-6.
Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme.
Cooksey L, Friesen D, Mangan E, Mathew P
Cells. 2024; 13(18.
PMID: 39329751
PMC: 11429815.
DOI: 10.3390/cells13181567.
Roles in Innate Immunity.
Church K, Cardona A, Hopp S
Adv Neurobiol. 2024; 37:263-286.
PMID: 39207697
DOI: 10.1007/978-3-031-55529-9_15.
Zonulin as Gatekeeper in Gut-Brain Axis: Dysregulation in Glioblastoma.
Hagemeyer H, Hellwinkel O, Plata-Bello J
Biomedicines. 2024; 12(8).
PMID: 39200114
PMC: 11352073.
DOI: 10.3390/biomedicines12081649.
Microglial type I interferon signaling mediates chronic stress-induced synapse loss and social behavior deficits.
Tripathi A, Bartosh A, Mata J, Jacks C, Madeshiya A, Hussein U
Mol Psychiatry. 2024; 30(2):423-434.
PMID: 39095477
DOI: 10.1038/s41380-024-02675-6.
Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis.
Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E
Biomolecules. 2024; 14(7).
PMID: 39062538
PMC: 11275042.
DOI: 10.3390/biom14070824.
Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma.
Xu H, Zhao X, Luo J
Cell Mol Life Sci. 2024; 81(1):275.
PMID: 38907858
PMC: 11335198.
DOI: 10.1007/s00018-024-05300-5.
Polymicrobial brain abscesses: A complex condition with diagnostic and therapeutic challenges.
Eichorn F, Kameda-Smith M, Fong C, Graham A, Main C, Lu J
J Neuropathol Exp Neurol. 2024; 83(10):798-807.
PMID: 38874452
PMC: 11413443.
DOI: 10.1093/jnen/nlae058.
'Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review'.
Tang H, Rao A, Peters C, Ambulkar T, Ho M, Wang B
J Cancer. 2024; 15(11):3495-3509.
PMID: 38817862
PMC: 11134445.
DOI: 10.7150/jca.93306.
Red cell distribution width to lymphocyte ratio could serve as a new inflammatory biomarker for predicting hematoma expansion in patients with intracerebral hemorrhage.
Guilan M, Bagheri S, Roshani R, Alimohammadi E
BMC Neurol. 2024; 24(1):162.
PMID: 38750430
PMC: 11095002.
DOI: 10.1186/s12883-024-03669-1.
The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology.
Amoriello R, Memo C, Ballerini L, Ballerini C
Mol Brain. 2024; 17(1):4.
PMID: 38263055
PMC: 10807071.
DOI: 10.1186/s13041-024-01077-7.
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.
Gardam B, Gargett T, Brown M, Ebert L
Front Immunol. 2023; 14:1261257.
PMID: 37928547
PMC: 10623138.
DOI: 10.3389/fimmu.2023.1261257.
CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma.
Chen D, Varanasi S, Hara T, Traina K, Sun M, McDonald B
Immunity. 2023; 56(9):2086-2104.e8.
PMID: 37572655
PMC: 11800830.
DOI: 10.1016/j.immuni.2023.07.015.
Cutting-edge advances in modeling the blood-brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain.
Sharma A, Fernandes D, Reis R, Golubczyk D, Neumann S, Lukomska B
Cell Biosci. 2023; 13(1):137.
PMID: 37501215
PMC: 10373415.
DOI: 10.1186/s13578-023-01079-3.